Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System
Completed · Not applicable
Conditions studied: Peripheral Arterial Disease, Vascular Disease, Peripheral
In brief
Prospective, multi-center, single-arm study of the M5+ Peripheral IVL system to treat calcified peripheral arteries.
Key facts
- Study ID
- NCT04585763
- Run by
- Shockwave Medical, Inc.
- People needed
- 37
- Starts
- 2021-02-16
- Expected to finish
- 2022-11-21
- Last updated by the study team
- 2024-01-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Midwest Cardiovascular Research Foundation — Davenport, Iowa, United States
- NC Heart and Vascular Research — Raleigh, North Carolina, United States
- St. John Clinic — Bartlesville, Oklahoma, United States
- Prince of Wales Hospital — Randwick, New South Wales, Australia
- Perth Institute of Vascular Research — Nedlands, Western Australia, Australia
- Auckland City Hospital — Auckland, New Zealand
- Christchurch Hospital — Christchurch, New Zealand
- Waikato District Hospital — Hamilton, New Zealand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.